Why Ginkgo Bioworks Holdings Stock Raced 9% Higher Today
The company is forging ahead with next-generation drug development solutions.
Down a Monstrous 90% This Year, Is There Any Hope Left for Ginkgo Bioworks Investors?
Could this beaten-down stock turn things around in the near future?
2 Big Risks and 2 Big Opportunities for Ginkgo Bioworks Stock
The risks may resolve in a year or so but seizing the opportunities will take longer.
This 1 AI Stock Could Revolutionize Biotech and Pharma
The company is using artificial intelligence, and planning to help others use AI empowered by its data collection.
Down 88% in 1 Year, What's Next for Ginkgo Bioworks Stock?
Its ambitious business model may not be sustainable.
Down 86% This Year, Is Ginkgo Bioworks Stock a Bargain Now?
Have shares of the troubled life sciences business fallen too far?
Prediction: Artificial Intelligence Will Lead to Higher Returns With Biotech Stocks
Efficiency in core processes is set to increase substantially due to AI.
Down 81% in 2024, Is Ginkgo Bioworks Stock Still a Buy?
A recovery plan is underway, but it isn't a slam dunk.
Why Ginkgo Bioworks Stock Is Sinking Today
There was double trouble for this beaten-down biotech stock.
Bull Market and Beyond: 3 Stocks Just Waiting to Soar
These pharma and biotech players could become long-term winners.